Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion: A Prospective Physiologic Study

NCT02179944 is registered in ClinicalTrials.gov with Planned Parenthood League of Massachusetts as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02179944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion: A Prospective Physiologic Study
Lead sponsor
Planned Parenthood League of Massachusetts
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
March 31, 2015
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

undesired pregnancy